NL-OMON39109已完成不适用
Cardiovascular effects of apelin infusion in healthy male subjects - Cardiovascular effects of apelin infusion
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Eli Lilly
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •healthy male subjects
- •18-55 yrs, inclusive
- •BMI: 18.5-30.0 kg/m2, inclusive
- •non-smoking or less than 10 cigarettes/day
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study
研究者
相似试验
已完成
早期 1 期
Cardiovascular Effects of Apelin In Healthy VolunteersHealthyNCT02259686University of Edinburgh14
已完成
不适用
A clinical trial to study the effect of standard treatment of heart failure on plasma levels of Apelin in patients with heart failure.CTRI/2009/091/000935Department of Pharmacology AIIMSAnsari NagarNew Delhi50
已完成
不适用
Local Haemodynamic Effects of Apelin Agonists and Antagonists in Man in VivoCardiovascular DiseaseNCT02150694University of Cambridge52
Unknown
不适用
Effects of Apelin on the Lung Circulation in Pulmonary HypertensionHeart FailurePulmonary Arterial HypertensionNCT01457170Golden Jubilee National Hospital63
进行中（未招募）
1 期
This study is being carried out to evaluate the effect of a drug called dapagliflozin when added to current treatment for type 2 diabetes on cardiovascular events.Type 2 Diabetes mellitusMedDRA version: 20.0Level: SOCClassification code 10027433Term: Metabolism and nutrition disordersSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 20.0Level: LLTClassification code 10012613Term: Diabetes mellitus non-insulin-dependentSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2013-000239-28-DEAstraZeneca AB17,160